Research shows and the infectious disease community agrees that healthcare professionals working with preteens, teens, and young adults must:
- Make a strong recommendation for HPV vaccination
- Clearly indicate that HPV vaccine is cancer prevention
NFID has information, tools, and resources for healthcare professionals and epidemiologists to help increase HPV vaccination rates for males and females at the recommended ages for vaccination.
The Centers for Disease Control and Prevention (CDC) recommends 11- to 12-year-olds get two doses of HPV vaccine to protect against cancers caused by HPV. The second dose should be given 6-12 months after the first dose. Those who initiate the vaccination series after age 15 years as well as those who are immunocompromised should receive three doses.
Both males and females up to age 26 years who were not adequately vaccinated should receive catch-up HPV vaccination.
Adults age 27-45 years should talk to a healthcare professional about whether HPV vaccination is right for them. Shared clinical decision-making is recommended because some individuals who are not adequately vaccinated might benefit from vaccination.
View additional information on the CDC recommendations.
Infographic highlighting steps to make HPV vaccination routine
Best practices and educational tools for increasing HPV immunization rates in preteens, teens, and young adults
Resources designed to help healthcare professionals communicate the importance of HPV vaccination in preventing cancer